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TWEAKing Muscle Regeneration
Although skeletal muscle can regenerate in vivo, inflam-
matory molecules are thought to inhibit this process,
resulting in muscle-wasting disease. Mittal et al (Am J
Pathol 2010, 177:1732–1742) discovered that expression
of proinflammatory cytokine TNF-like weak inducer of
apoptosis (TWEAK) and its receptor Fn14 are increased
in muscles after injury. TWEAK deficiency enhanced met-
rics of muscle regeneration and decreased levels of in-
flammatory mediators such as NF-B, whereas induced
TWEAK expression inhibited muscle regeneration as well
as increased levels of inflammatory mediators. TWEAK
inhibition may therefore provide a novel therapeutic tar-
get for muscle regeneration.
Antiviral CD8 T Cells Protect against
Multiple Sclerosis
In a Theiler’s murine encephalomyelitis virus (TMEV)
model of multiple sclerosis, CD8 T cells specific for the
immunodominant viral peptide protect against demyeli-
nating disease. Using confocal microscopy and live tis-
sue imaging, McDole et al (Am J Pathol 2010, 177:1823–
1833) explored the interactions of virus-specific CD8 T
cells with different cell types in the central nervous sys-
tem. Antiviral CD8 T cells became activated in conjunc-
tion with infected neurons; these cells polarized their T
cell receptors, CD8, and granzyme B toward infected
neurons, despite low neuronal expression levels of MHC
class I molecules. CD8 T cells also extended cytoplas-
mic processes to neurons, a mechanism thought to be
involved in T cell migration. The direct interactions be-
tween CD8 T cells and neurons could mediate the pro-
tective role played by these cells in TMEV-mediated mul-
tiple sclerosis.
Prion Protein Mediates HIV-Associated
Neuroinflammation
Nearly half of HIV-infected individuals develop neurocog-
nitive impairment due to the presence of HIV in the cen-
tral nervous system (CNS). Roberts et al (Am J Pathol
2010, 177:1848–1860) hypothesized that PrPc (protease-
resistant protein), the nonpathological cellular isoform of
prion protein, plays a role in CNS disease associated with
HIV infection. PrPc levels were increased in the CNS of
HIV-infected individuals, and PrPc was secreted in the
cerebrospinal fluid at levels comparable to that observed in
individuals with neurocognitive impairment. Indeed, HIV in-
fection altered the levels of PrPc released from peripheral
bloodmononuclear cells. Moreover, PrPc could induce neu-
roinflammation by inducing the production of inflammatory
mediators by astrocytes. Taken together, these data sug-
gest that PrPc may provide a novel biomarker for HIV-
associated cognitive decline and may play a direct role in
mediating HIV-associated neuroinflammation.
Epigenetic Control of Fibrosis
Liver fibrosis, which is primarily mediated by hepatic
stellate cells, is characterized by the suppression of ma-
trix metalloproteinases (MMPs) and the coordinate accu-
mulation of extracellular matrix. To determine the mech-
anism underlying MMP repression in liver fibrosis, Qin et
al (Am J Pathol 2010, 177:1915–1928) examined key
signaling pathways involved in MMP expression. They
found that MMP transcription was inhibited due to im-
paired transcription factor recruitment via decreased lev-
els of histone acetylation in hepatic stellate cells. This
inhibition was accompanied by an accumulation of histone
deacetylase 4, and histone deacetylase 4 expression in
hepatic stellate cells resulted in decreased levels of MMP
expression. Therefore, an epigenetic switch contributes to
MMP repression in liver fibrosis.
AIP (Aryl Hydrocarbon Receptor-Interacting
Protein) Mutation Predisposes to Pituitary
Adenomas
Pituitary adenomas are benign tumors of the anterior
pituitary gland that result in secretion of excess pituitary
hormones such as growth hormone or prolactin. To fur-
ther study pituitary adenomas, Raitila et al (Am J Pathol
2010, 177:1969–1976) generated a mouse model defi-
cient in AIP, which has been correlated with predisposi-
tion to pituitary adenomas in humans. Mice heterozygous
for AIP were strongly predisposed to developing growth
hormone–secreting pituitary adenomas but not other tu-
mor types, and these tumors presented with an aggres-
sive phenotype. In addition, similar to human tumors,
expression of aryl hydrocarbon receptor nuclear translo-
cator 1 or 2 (ARNT or ARNT2) protein was lost in the
mouse tumors. Thus, mice deficient in AIP provide a
novel model to study human pituitary adenomas.
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